ArticleAnnals of surgical oncology2025

Activated Hippo Pathway is Associated with a Worse Response to Trastuzumab and Worse Survival in HER2-Positive Breast Cancer.

Masanori Oshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.